A theme concerning 4503's aim of returning to sustainable growth under Management Plan 2018 through product value maximization, Operational Excellence, a Focus Area approach and the Rx+ program. It includes the failure to meet the sales target in the plan's final year and the achievement of targets for R&D expenses, core operating margin and core EPS.